| Bioactivity | Ifidancitinib (ATI-50002) is a potent and selective inhibitor of JAK kinases 1/3. Ifidancitinib can be used in studies of allergies, asthma and autoimmune diseases[1]. | ||||||||||||
| Name | Ifidancitinib | ||||||||||||
| CAS | 1236667-40-5 | ||||||||||||
| Formula | C20H18FN5O3 | ||||||||||||
| Molar Mass | 395.39 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Li, Hui; Heckrodt, Thilo J.; Chen, Yan; Mcmurtrie, Darren John; Taylor, Vanessa; Singh, Rajinder; Ding, Pingyu; Yen, Rose.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1 |
Ifidancitinib
CAS: 1236667-40-5 F: C20H18FN5O3 W: 395.39
Ifidancitinib (ATI-50002) is a potent and selective inhibitor of JAK kinases 1/3. Ifidancitinib can be used in studies o
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.